Fig. 1From: Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s diseaseMIF, sTREM1, and sTREM2 levels in CSF are changed in different diagnostics groups. Raw values are presented and differences between groups were tested by ANCOVA adjusted for age or sex when applicable. We detected increased MIF levels in MCI and AD (A), sTREM1 was detected to be increased in AD (B), and increased sTREM2 levels were detected in MCI (C). Boxplots represent the median ± interquartile range. * P < 0.05, ** P < 0.01, *** P < 0.001. MCI mild cognitive impairment, AD Alzheimer’s disease, DLB dementia with Lewy bodies, MIF macrophage migration inhibitory factor, sTREM1 soluble triggering receptor expressed on myeloid cells 1, sTREM2 soluble triggering receptor expressed on myeloid cells 2Back to article page